Covaxin Efficacy 77.8% In Lancet Study; 65.2% Against Delta In Early Data - TMS ShortLINK
News Update
Loading...
Without Label Covaxin Efficacy 77.8% In Lancet Study; 65.2% Against Delta In Early Data

Thursday, November 11, 2021

Covaxin Efficacy 77.8% In Lancet Study; 65.2% Against Delta In Early Data

      Comment   
----YOU ADS---
----YOU ADS---
Covaxin, the coronavirus vaccine developed by the government's medical research agency and Bharat Biotech, was found to have a 77.8 per cent efficacy rate against symptomatic COVID-19 in a... ----YOU ADS---
----YOU ADS---

Share with your friends

Give us your opinion

How To Use
  • Put the link on the
  • Generate Link box with http:// or https://
  • Use  CTRL + V  on keyboard to put the link.
  • Click Generate button to get encrypted link.
  • Click Copy URL button.
    • Done